Open access
Open access
Powered by Google Translator Translator

General Gynecology

O-RADS MRI Risk Stratification System: Guide for Assessing Adnexal Lesions from the ACR O-RADS Committee.

20 Jan, 2022 | 08:59h | UTC

O-RADS MRI Risk Stratification System: Guide for Assessing Adnexal Lesions from the ACR O-RADS Committee – Radiology

 


Review: Diagnosis and treatment of polycystic ovary syndrome.

20 Jan, 2022 | 08:54h | UTC

Diagnosis and Treatment of Polycystic Ovary Syndrome – JAMA (free for a limited period)

 


Cohort Study: Factors associated with 10-year declines in physical health and function among women during midlife.

19 Jan, 2022 | 08:29h | UTC

Factors Associated With 10-Year Declines in Physical Health and Function Among Women During Midlife – JAMA Network Open

Commentary: Four Factors in Midlife Predict a Healthy Old Age for Women – HealthDay

 


Association of hormonal contraceptive use with adverse health outcomes: an umbrella review of meta-analyses of randomized clinical trials and cohort studies.

18 Jan, 2022 | 09:29h | UTC

Association of Hormonal Contraceptive Use With Adverse Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials and Cohort Studies – JAMA Network Open

 


M-A: Combined oral contraceptives may improve overall premenstrual symptomatology but are not helpful for premenstrual depressive symptoms.

14 Jan, 2022 | 07:49h | UTC

Efficacy of combined oral contraceptives for depressive symptoms and overall symptomatology in premenstrual syndrome: pairwise and network meta-analysis of randomized trials – American Journal of Obstetrics & Gynecology

Commentary: ‘Optimal’ treatment for premenstrual depressive symptoms remains elusive – Healio (free registration required)

 


Risk of reoperation 10 years after surgical treatment for stress urinary incontinence: a national population-based cohort study.

14 Jan, 2022 | 07:51h | UTC

Risk of reoperation 10 years after surgical treatment for stress urinary incontinence: a national population-based cohort study – American Journal of Obstetrics & Gynecology

 

Commentary on Twitter

 


Review: Diagnosis and treatment of sexually transmitted infections.

13 Jan, 2022 | 08:38h | UTC

Diagnosis and Treatment of Sexually Transmitted Infections: A Review – JAMA (free for a limited period)

 


Systematic Review: The effectiveness and safety of treatments for recurrent vulvovaginal candidiasis.

11 Jan, 2022 | 02:24h | UTC

Treatment for recurrent vulvovaginal candidiasis (thrush) – Cochrane Library

Summary: The effectiveness and safety of treatments for recurrent vulvovaginal candidiasis (thrush) – Cochrane Library

 


FDA approves first injectable treatment for HIV pre-exposure prevention.

8 Jan, 2022 | 23:04h | UTC

FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention – U.S. Food & Drug Administration

Commentaries:

NIH celebrates FDA approval of long-acting injectable drug for HIV prevention – NIH News Releases

A new injection to prevent HIV, rather than pills, is a game-changer, scientists say – NPR

Related:

CDC Guidance: Preexposure Prophylaxis for Prevention of HIV Acquisition Among Adolescents

Study Shows High Burden of STI Among Individuals Using Preexposure Prophylaxis for the Prevention of HIV Infection

USPSTF Statement: Preexposure Prophylaxis for the Prevention of HIV Infection

British Guidelines on the Use of HIV Pre–exposure Prophylaxis (PrEP) (several guidelines on the subject)

New Protocol for HIV Prevention Drug Reduces The Number Of Pills Required

 


Abortion safety and use with normally prescribed Mifepristone in Canada.

16 Dec, 2021 | 08:51h | UTC

Abortion Safety and Use with Normally Prescribed Mifepristone in Canada – New England Journal of Medicine

News Release: Prescribing the abortion pill without restrictions is safe and effective, study finds – University of British Columbia

 


Short Review: Lymphogranuloma venereum.

14 Dec, 2021 | 08:42h | UTC

Lymphogranuloma venereum – Canadian Medical Association Journal

 


NICE Guideline | Pelvic floor dysfunction: prevention and non-surgical management.

13 Dec, 2021 | 09:43h | UTC

Pelvic floor dysfunction: prevention and non-surgical management – National Institute for Health and Care Excellence

 


Review: Endometrial cancer.

13 Dec, 2021 | 08:43h | UTC

Endometrial cancer – Nature Reviews Disease Primers (free for a limited period – if the link is paywalled, try this one)

Infographic: Endometrial cancer (free for a limited period – if the link is paywalled, try this one)

 


Cohort Study: Association of bilateral salpingo-oophorectomy with all cause and cause specific mortality.

13 Dec, 2021 | 08:42h | UTC

Association of bilateral salpingo-oophorectomy with all cause and cause specific mortality: population based cohort study – The BMJ

Commentary: Bilateral salpingo-oophorectomy may have risks for younger women, but safe for post-menopausal patients – News Medical

 

Commentary on Twitter

 


Evaluation and management of pelvic organ prolapse.

8 Dec, 2021 | 09:50h | UTC

Evaluation and Management of Pelvic Organ Prolapse – Mayo Clinic Proceedings

 


RCT: Cytoreductive surgery for relapsed ovarian cancer.

2 Dec, 2021 | 09:51h | UTC

Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer – New England Journal of Medicine

 


[Not published yet] Single-dose HPV vaccine highly effective, researchers say – “Results of randomized controlled trial in Kenya bring new energy to eliminate cervical cancer worldwide”.

21 Nov, 2021 | 22:56h | UTC

Single-dose HPV vaccine highly effective, researchers say – University of Washington School of Medicine

Related:

A national HPV vaccination program in England was associated with an estimated reduction in cervical cancer rates of 87% for those offered the vaccine at age 12–13 years.

Three-year follow-up of 2-dose versus 3-dose HPV vaccine

Nationwide cohort study in Sweden shows HPV vaccination linked to reduced risk of invasive cervical cancer

CDC: 92% of Human Papillomavirus–Attributable Cancers can be Targeted by HPV Vaccination

Meta-Analysis: Population-level Impact of HPV Vaccination Programs

 


Recommendations for women with gynecological cancer who received non-standard care during the COVID-19 pandemic.

19 Nov, 2021 | 10:33h | UTC

British Gynaecological Cancer Society recommendations for women with gynecological cancer who received non-standard care during the COVID-19 pandemic – International Journal of Gynecological Cancer

 


Large observational study suggests prolactin-increasing antipsychotics are associated with increased risk of breast cancer (OR=1.56 for over 5 years of exposure); prolactin-sparing antipsychotics (including clozapine, quetiapine, or aripiprazole), on the other hand, were not associated with increased risk.

10 Nov, 2021 | 06:57h | UTC

Antipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland – The Lancet Psychiatry (link to abstract – $ for full-text)

Commentary: Choosing between antipsychotics to reduce the risk of breast cancer in women with schizophrenia – The Mental Elf

 

Commentary on Twitter

 


A national HPV vaccination program in England was associated with an estimated reduction in cervical cancer rates of 87% for those offered the vaccine at age 12–13 years.

4 Nov, 2021 | 09:58h | UTC

The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study – The Lancet

Related:

Nationwide cohort study in Sweden shows HPV vaccination linked to reduced risk of invasive cervical cancer

CDC: 92% of Human Papillomavirus–Attributable Cancers can be Targeted by HPV Vaccination

Meta-Analysis: Population-level Impact of HPV Vaccination Programs

 

Commentary on Twitter

 


Cohort Study: Hypertensive disorders of pregnancy are associated with a 6-fold or higher increased risk of chronic hypertension in the first years following delivery.

21 Oct, 2021 | 09:51h | UTC

Hypertensive disorders of pregnancy and onset of chronic hypertension in France: the nationwide CONCEPTION study – European Heart Journal

Editorial: Impact of hypertensive disorders of pregnancy: lessons from CONCEPTION

 

Commentary on Twitter

 


RCT: Laser treatment not better than sham treatment on symptom severity in women with postmenopausal vaginal symptoms.

13 Oct, 2021 | 01:30h | UTC

Effect of Fractional Carbon Dioxide Laser vs Sham Treatment on Symptom Severity in Women With Postmenopausal Vaginal Symptoms: A Randomized Clinical Trial – JAMA (free for a limited period)

News release: This laser is supposed to rejuvenate vaginal tissue. But scientists say it’s no better than a placebo – University of New South Wales

Editorial: Time for a “Pause” on the Use of Vaginal Laser (free for a limited period)

Author Interview: Effect of Carbon Dioxide Laser vs Sham Therapy on Women With Postmenopausal Vaginal Symptoms

Commentary: Vagina lasering for postmenopausal women ‘may be placebo’ – The Guardian

 

Commentary on Twitter

 


Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018.

13 Oct, 2021 | 01:21h | UTC

Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018 – Nature Medicine

Invited commentary: Anemia in women — an intractable problem that requires innovative solutions – Nature Medicine

 


WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017–18 – In many countries, ciprofloxacin resistance was exceedingly high, and decreased susceptibility or resistance to ceftriaxone and cefixime continued to emerge.

24 Sep, 2021 | 08:53h | UTC

WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017–18: a retrospective observational study – The Lancet Microbe

 


RCT: Tamsulosin may prevent postoperative urinary retention following female pelvic reconstructive surgery.

17 Sep, 2021 | 09:56h | UTC

Tamsulosin vs placebo to prevent postoperative urinary retention following female pelvic reconstructive surgery: a multicenter randomized controlled trial – American Journal of Obstetrics & Gynecology (link to abstract – $ for full-text)

 


Stay Updated in Your Specialty

No spam, just news.